SB2556Enacted

Amends TCA Title 39; Title 53; Title 63 and Title 68.

Tennessee SB2556 mandates the Department of Health to compile and submit a report detailing each medication approved by the FDA for women's health, including a synopsis of each medication, to the Speaker of the Senate and the Speaker of the House of Representatives by January 1, 2027. This bill affects the Department of Health and the legislative bodies by ensuring they receive updated information on women's health medications. Key provisions include the requirement for a comprehensive report and a specified deadline for submission.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee SB2556 mandates the Department of Health to compile and submit a report detailing each medication approved by the FDA for women's health, including a synopsis of each medication, to the Speaker of the Senate and the Speaker of the House of Representatives by January 1, 2027. This bill affects the Department of Health and the legislative bodies by ensuring they receive updated information on women's health medications. Key provisions include the requirement for a comprehensive report and a specified deadline for submission.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Reeves, Shane

Details
Session

114th General Assembly

Introduced

February 2, 2026

Last Action

May 26, 2026

Comp. became Pub. Ch. 1008

Subjects
Controlled SubstancesHealth, Dept. ofPhysicians and SurgeonsDrugs, Prescription

Want to track this bill? Get instant alerts and AI-powered insights.

SB2556: Amends TCA Title 39; Title 53; Title 63 and Title 68. | LegisGo